News
20181019 092323

On October 19th, during a “Prostate Cancer Wakeup Call”, the Prostate Cancer Foundation has raised a total of $61,530. A portion of this amount will benefit the Atlantic Cancer Research Institute. We would like to thank all the people involved with this event and also all the people that were present during this fundraiser for prostate cancer research.
Tournoi de Golf Banque Nationale 2018


(Moncton, NB) September 13th, 2018 - On September 13th, during a golf tournament at the Fox Creek Golf Club, the National Bank, their employees and their sponsors have raised $25000 dollars to benefit the Atlantic Cancer Research Institute. We would also like to thank Stéphane Achard, Executive Vice President of Commercial Banking & Insurance at the National Bank, for an additional donation of $10000 dollars for a grand total of $35000 dollars.

ACRI would like to thank the National Bank and all those involved for their generous support.
IMG 2365

( Moncton, NB )- August 10th, 2018 -Yesterday, during a golf tournament to benefit the Atlantic Cancer Research Institute (ACRI), Assumption Life, their employees and their sponsors have raised fifty thousand dollars.

ACRI would like to thank Assumption-Life and all those involved for their generous support.
Image may contain: 3 people, people standing and indoor
( Moncton, NB )- July 27, 2018 - Yesterday, we had the pleasure of welcoming the New Brunswick Minister of Health, Mr. Benoît Bourque, at the Atlantic Cancer Research Institute (ACRI). Dr. Jocelyn Paré gave him a tour of our research laboratories and presented him with details about the activity he leads at ACRI, namely an ablation technology that combines the advantages of chemical ablation to those of microwave ablation.


(Moncton, NB) - June 7th, 2018 - Dooly's franchisees, their employees and customers have officially raised a grand total of $1 million over the last 13 years in support of the Atlantic Cancer Research Institute (ACRI). ACRI would like to thank Dooly's and all those involved for their generous support over the years and for reaching this great achievement. 

For information on how you could support the Atlantic Cancer Research Institute, please contact

Remi Richard
Business Development Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone : +1 506 869 2048
Fax : +1 506 862 7571
Moncton, New Brunswick -- (January 9, 2018) - Atlantic Cancer Research Institute is pleased to announce the European Patent Office (EPO) has granted as of December 27, 2017 Patent Application No. 2688904 entitled: POLYPEPTIDES WITH AFFINITY FOR HEAT SHOCK PROTEINS (HSPS) AND HSP ASSOCIATED COMPLEXES (HACS) AND THEIR USE IN DIAGNOSIS AND THERAPY. 

ACRI also holds a granted patent for this technology in the United States (US Patent # 8,956,878). ACRI's technology described in the patent includes the Vn96 peptide used for liquid biopsy applications. The peptide has a high affinity for heat shock proteins (HSPs) lining the surface extracellular vesicles (EVs). EVs contain a sample of the DNA, RNA, protein and metabolites found within the cells from which they are derived. Since EVs appear in blood, urine and other body fluids, they are a rich biomarker source that can be obtained by minimally-invasive methods to screen for diseases. 

The ACRI team is working to identify the specific proteins and nucleic acids that are released from cancer cells in these small biomarker packets. These cancer-specific proteins and nucleic acids hold the potential to be used as new biomarkers for cancer detection using a liquid biopsy. ACRI is focused on advancing its extracellular vesicle capture technologies to enable new cancer diagnostic, prognostic, and treatment-response tests. 

For technology information, collaborations or partnerships, please contact:

Remi Richard
Business Development Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone : +1 506 869 2048
Fax : +1 506 862 7571
Assumption Life Golf Tournament

(Moncton, NB) - August 11th, 2017 - The Assumption Life Golf Tournament raised $55,000 for the Atlantic Cancer Research Institute (ACRI). ACRI is very grateful to Assumption Life, the tournament participants, the tournament sponsors and special guest, Guy Lafleur. Thank you!
(Moncton, Canada) - March 15th, 2017 – The Atlantic Cancer Research Institute (ACRI) is pleased to announce an agreement with BioVendor – Laboratorní medicína a.s. to license its patented intellectual property for the use of the Vn96 synthetic peptide in liquid biopsy applications. The agreement gives BioVendor non-exclusive rights to use the Vn96 peptide for the isolation of extracellular vesicles for the diagnosis of diseases, such as cancer.

Extracellular vesicles (EVs), which include exosomes, are small cell-derived particles that are present within body fluids such as plasma and urine. EVs contain a sample of the DNA, RNA, protein, lipids and metabolites found within the cells from which they are derived and therefore are a valuable source of biomarkers that reflect the real-time state of both healthy and diseased cells. The Vn96 synthetic peptide, developed by ACRI and New England Peptide Inc. (Gardner, MA), is recognized as one of the leading technologies that enables EV capture from body fluids.

Liquid biopsy is a precision medicine technology that offers physicians and health professionals the ability to test a patient in real time to obtain multi-parametric biomarker information and guide therapeutic choices. The Vn96 peptide enables liquid biopsy by providing a fast and reproducible method for the isolation of EVs, and the information that they contain, which is clinically amenable and requires minimal specialized equipment.
DOWNLOAD PDF OF PRESS RELEASE




About BioVendor

BioVendor - Laboratorni medicina a.s. was established in the Czech Republic in 1992 as a distributor of clinical chemistry and life science laboratory products. The Research and Diagnostic Products division is an innovative biotechnology company focused on the development and manufacture of in vitro diagnostics and for-research-use immunoassays, recombinant proteins and antibodies. BioVendor’s R&D assays for in vitro diagnostics are aimed at rapidly growing fields of interest within the international research and diagnostic community, such as the oncology and liquid biopsy markets.

About ACRI
The Atlantic Cancer Research Institute is a private, not-for-profit research organization created in 1998 and located at the Dr. Georges-L.-Dumont University Hospital Centre in Moncton, NB, Canada. Unique to the region and operating a modern biomedical research laboratory, this entrepreneurial team is striving to innovate by accelerating its understanding of cancer, thus paving the way to better diagnosis, more accurate patient stratification and drug discovery.

Quotes
The license agreement is a very important piece in our strategy to bring innovative immunoassays that target miRNA as clinically valuable biomarkers.”- Viktor Růžička, M.D., CEO of BioVendor – Laboratorní medicína a.s.
We are very pleased to conclude this licensing agreement with an innovative company like BioVendor. We are confident that our extracellular vesicle isolation technology will be able to enhance their diagnostic and liquid biopsy products.” – Dr. Rodney Ouellette, President and Scientific Director of ACRI

-30-

For additional information, please contact:

Remi Richard, Business Development Agent
Atlantic Cancer Research Institute
T 506.862.7512
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
www.atlanticcancer.ca
ACRI RESEARCHERS
(Moncton, NB) – February 4th, 2017
– World Cancer Day, which takes place every year on February 4th, is an initiative under which the entire world can unite together in the fight against the global cancer epidemic. With research facilities located in Moncton, New Brunswick, the Atlantic Cancer Research Institute (ACRI) is an integral part of efforts of the world-wide scientific community to progress the battle against cancer.

“Breakthroughs in our knowledge of cancer biology are the key that allows innovation to reach the cancer patient.” says Dr. Rodney Ouellette, President and Scientific Director at ACRI. “This new knowledge allows for the development of improved tests for early detection and diagnosis on the one hand, while leading to improved tailoring of new treatments to the individual. We can now say that we are routinely analyzing individual cancer genomes and with our liquid biopsy technologies we are moving towards the real-time personalization of patient care.”

 SL 3889
September 14, 2016 Moncton – NB – (Atlantic Canada Opportunities Agency – ACOA)

Testing patients for cancer and other diseases will become more efficient and less painful as a result of an investment of up to $3 million from the Government of Canada.

Sylvain Mailhot
(Moncton, NB) – August 16, 2016 - The Atlantic Cancer Research Institute (ACRI) is pleased to welcome Dr. Sylvain Mailhot as an Associate Researcher.

‘Personalize My Treatment’ (PMT) Initiative aims to:
• Make Canada’s rich scientific resources accessible to the research community
• Create a comprehensive cancer database of tissue samples, genomic data and clinical
data from the cancer patient population
• Match patients to available clinical trials based on the profile of their cancer

Moncton, New Brunswick - April 18, 2016 - At an announcement made earlier today at the Dr. Georges-L.-Dumont University Hospital Centre, Merck, known as MSD outside the United States and Canada, confirmed its commitment to research and innovation in oncology by contributing a total of $2 million to the Exactis Innovation ‘Personalize My Treatment’ (PMT) initiative. In addition, the Cancer Research Society (CRS) and the New Brunswick Health Research Foundation (NBHRF) will also contribute $1 million each to help bring innovative precision medicine to Canadians living with cancer.

(Moncton, N.B.) – March 30, 2016 - The Atlantic Cancer Research Institute (ACRI) today announced the successful completion of a $10 million fundraising campaign, the largest in the Institute’s celebrated 15 year history.
“Over its first fifteen years the Atlantic Cancer Research Institute has had some significant accomplishments and now with the successful completion of this $10 million fundraising campaign the Institute is looking toward an even brighter future,” according to ACRI President Dr. Rodney Ouellette.

(Moncton, N.B.) – March 21, 2016 -- The Atlantic Cancer Research Institute (ACRI) will present improvements on its patented peptide-based extracellular vesicle isolation technology today at the Circulating Biomarkers World Congress (CBWC) in Boston. These enhancements to this first-in-class liquid biopsy-enabling technology will open up opportunities for better disease management as it applies to early detection, diagnosis and monitoring of treatment response. This technology yields cancer biomarkers using a minimally-invasive approach that complements and may eventually eliminate the need for invasive tissue biopsies as a means to identify and monitor disease in real time.

By Dr. Rodney Ouellette, M.D., Ph.D.

New Brunswick faces daunting challenges in the delivery of health care services to residents. The current public debate between Saint John and Moncton regarding investment in a duplicate gene sequencing facility is another example of the consequences when we overlook opportunities to collaborate and optimize.

Patients want and need access to the best available diagnostic technologies. In the area of gene sequencing we already have the capability right here in New Brunswick through Vitalité Health Network and Atlantic Canada Research Institute (ACRI). The Molecular Genetics Laboratory is located in and part of the Dr GL Dumont University Hospital laboratories which was accredited in September 2014 by the Institute for Quality Management in Healthcare (formerly Ontario Laboratories Association). Any clinician in New Brunswick can access this testing through the Vitalité Health Network. Our professionals are skilled and available for consultation. Our service is timely and costs are comparable or lower to those charged by other labs operating outside of the province. As good stewards of health care dollars we believe should be using this existing facility taking advantage of our capacity before investing in another lab when there are so many pressing priorities to improving health care in our province.

Jocelyn Paré
The Atlantic Cancer Research Institute is very happy to welcome Dr. Jocelyn Paré, recipient of the New Brunswick Innovation Research Chair in Medical Technologies.

team
Justin Bujold, Roxann Guerrette, Rémi Richard et Annie-Pier Beauregard

Acute Lymphoblastic Leukemia (ALL) is rarely found in adults but will affect more than a fourth of children diagnosed with cancer. With around 90% remission, this cancer is still a very morbid disease with high mortality rates.
Personalized medicine is the most promising alternative to fight cancer. Briefly, this new procedure allows for the detection of specific mutations indicative of a specific cancers allowing doctors to access better treatment.

Benzina photo
Sami Benzina : Featured research trainee by the Beatrice Hunter Cancer Research Institute
READ FEATURE
Lab wide angle 06

(Moncton, N.B.) – February 4th, 2015 – Taking place under the tagline 'Not beyond us', World Cancer Day takes a positive and proactive approach to the fight against cancer, highlighting that solutions do exist across the continuum of cancers, and that they are within our reach. This year's campaign focuses on four key areas: choosing healthy lives, delivering early detection, achieving treatment for all and maximising quality of life.

relish  ACRI 

(Moncton, NB) – Friday, January 30, 2015 – Imagine if everyone one the planet was "inspired to Relish their life through their dreams, passions and aspirations."

This is exactly what inspires reLiSH Gourmet Burgers to make a difference in people and their journey on Earth. Their mission to reLiSH life is what has inspired reLiSH Gourmet Burgers all across Atlantic Canada to team up with the Atlantic Cancer Research Institute in the fight against cancer with the creation of The Terminator burger. Last year, for its first edition, relish created the Terminator which is made-up of reLiSH's signature burger The Simpleton™ topped off with salsa, avocado, pepper jack cheese and crispy bacon. This burger had a warm welcome and was such a success that people wanted more and kept requesting it after the event was over. It took one year for the return of the Terminator which will be featured at your local reLISH burger restaurant in light of World Cancer Day. A portion of the sales from each Terminator burger sold on February 3rd and 4th will be donated to the Atlantic Cancer Research Institute.

"reLiSH Gourmet burgers and our franchisee operators are really excited about the Terminator program this year," says Rivers Corbett, co-founder of reLiSH Gourmet Burgers. "ACRI is a key community partner and we relish this opportunity to help out. This mouth-watering burger is sure to leave you completely satisfied, not only because it tastes so good, but also because by purchasing one, you know you'll be supporting a great cause – terminating cancer."

"We at ACRI are extremely grateful to be able to partner with community leaders like reLiSH Gourmet Burgers in such initiatives," says Sophie Thériault, Director of Business Development and Communications at ACRI. "More than one out of three people in Atlantic Canada will be affected by this terrible disease and raising money to fight to terminate cancer with innovative and motivated partners helps us make a difference. We are thankful to reLiSH Gourmet Burgers for supporting, for the second year in a row, the Atlantic Cancer Research Institute with this pan-Atlantic initiative and invite you to go and try The Terminator. They really are delicious!"

Those who can't let go of their favorite reLiSH burger will be able to make a donation in the amount of their choice, write their name on an "Atlantic Cancer Research Institute" Logo and the staff at reLiSH gourmet burgers will proudly put it up for everyone to see the supporters who encourage cancer research conducted right here in Atlantic Canada!

Visit any of the four reLish locations in Fredericton, Halifax and St. Johns and help us in the fight to terminate cancer.

About Atlantic Cancer Research Institute
The Atlantic Cancer Research Institute (ACRI) is a private, not for profit research organization created in 1998. Located at the Dr.- George-L. Dumont University Hospital in Moncton, NB, it employs a multidisciplinary research team of over 50 people. Unique to the region and operating a modern biomedical research laboratory, this entrepreneurial team is striving to innovate by accelerating its understanding of cancer, thus paving the way to better diagnosis, more accurate patient stratification and drug discovery.

For more information, please visit www.atlanticcancer.ca or on Facebook, Atlantic Cancer Research. www.cancerresearchsaveslives.ca

-30-

For further information:
riVeRS Corbett
co-founder
reLiSH Gourmet Burgers
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.reLiSHCanada.com
www.riVeRSCorbett.me


Terminator Poster English
logo ccs

NEW BRUNSWICK, October 30, 2014 - The Canadian Cancer Society, in partnership with the New Brunswick Health Research Foundation and Craig's Cause Pancreatic Cancer Society, has announced a grant of $197,500 to support New Brunswick cancer research scientists exploring the development of a blood test to detect pancreatic cancer at an early stage.

"The survival rate for pancreatic cancer is only eight percent, so finding a way to detect it earlier could significantly improve outcomes for many patients," said Anne McTiernan-Gamble, CEO of the Canadian Cancer Society New Brunswick. "We're extremely pleased to partner with Craig's Cause Pancreatic Cancer Society and the New Brunswick Health Research Foundation in funding this exciting research, led by Drs. Stephen Lewis, Rodney Ouellette and Anirban Ghosh."

Vn96 pub

ACRI`s research team publishes article detailing its research on extracellular vesicle isolation.

Rapid Isolation of Extracellular Vesicles from Cell Culture and Biological Fluids Using a Synthetic Peptide with Specific Affinity for Heat Shock Proteins
station 2014 collage1
This year's National Biotechnology Week proved that New Brunswick is home to more than just a strong biosector – it's a community.

*Article published by BioNB on October 10th 2014

2013-2014 has seen more companies, more industry-research partnerships, more government investment, and more cross-sectoral events and meetings that are shaping the future of our province. Click here to see our timeline of highlights from the previous two years.

National Biotechnology Week is the nation-wide awareness week for the biosciences industry. The New Brunswick events hosted by BioNB were met with a level of participation and enthusiasm that was a welcome surprise. BioNB takes this as a sign that the sector is united, passionate, and gaining recognition as the sector to watch in the province of New Brunswick.

Between September 29th and 30th BioNB hosted the second annual NB Bioscience Twitter Scavenger Hunt. LuminUltra Technologies sponsored the two amazing prizes that were awarded to two very dedicated tweeters. Over two days, dozens of Twitter users religiously followed @BioScienceNB for clues and tasks related to bioscience in our province. Some of the tasks had participants finding creative uses for test tubes, doing some serious online detective work, and even filming their own sales pitches! In the end it was the sector that won. There were over 400 total #nbw2014 tweets, a 10% increase in our Twitter followers, and exposure for over 30 researchers, companies, and individuals. Click here to read our full recap of the Twitter Scavenger hunt.

LVER ACRI
Dr. Gilles A. Robichaud, Researcher at the ACRI, and La Vie en Rose Champlain Place store employees.

LA VIE EN ROSE DONATES $2,500 TO THE ATLANTIC CANCER RESEARCH INSTITUTE FOR BREAST CANCER RESEARCH


Montreal, October 6th, 2014 – Today, La Vie en Rose, through its Roses of Hope Foundation, donated $2,500 to the Atlantic Cancer Research Institute for breast cancer research. The donation took place at the La Vie en Rose Champlain Place store in Dieppe, in the presence of the retailer's store employees and the beneficiary organization's representatives.

open house

*Article published by BioNB on October 2nd 2014

During National Biotechnology Week 2014 we toured the Atlantic Cancer Research Institute in the Dr. Georges-L.-Dumont University Hospital Centre in Moncton, New Brunswick. Our tour guide, Ian Chute, who has been ACRI's Laboratory Manager for 7 years, led a group of curious visitors through ACRI's state of the art molecular biology labs.

ACRI has grown from a team of one into a 50+ member organisation of talented researchers and staff. After developing and commercializing a revolutionary method that will improve cancer detection, they continue to innovate. The centre is focused on three main areas of cancer research: early detection of disease, enhanced diagnosis, and targeted treatment.

logo institut

The Atlantic Cancer Research Institute Open House: Discover the lab and meet the staff!
Cancer isn't invincible. There are solutions. Research remains our greatest ally in the fight against cancer.

ACRI has grown from a team of one into a 50+ member organisation of talented researchers and staff. After developing and commercialising a revolutionary method that will improve cancer detection, we continue to innovate.

Come see our state-of-the-art cancer research lab and meet our researchers and staff! We will be offering guided tours to guests as well as the opportunity to engage with our scientists to learn about their innovative research such as our Vn96 technology and our next generation sequencing.

What: Guided tours, refreshments and networking

Where: The Atlantic Cancer Research Institute
35 Providence, Hôtel-Dieu Pavilion, 4th Floor. Moncton, NB E1C 8X3

When: September 30th between 1PM and 4PM
* There will be visits starting approximately every 30 minutes.
Who: Anyone interested in learning more about ACRI's cutting edge research. All are welcome!

Click here to RSVP

www.atlanticcancer.ca
CancerResearchSavesLives.ca


NBW

BioNB
news panel

The Vitalité Health Network, in collaboration with the Atlantic Cancer Research Institute (ACRI), is pleased to announce that the Molecular Diagnostic and Sequencing Laboratory at Dr. Georges-L.-Dumont University Hospital Centre is now equipped with a new, enhanced sequencing panel for the diagnosis of numerous cancers. The new panel, called the Cancer Hotspot v2, is being used alongside the panel in operation at the laboratory since March 2014 in the diagnosis of patients with lung and colon cancers.

Unlike the lung and colon cancer panel, which supports the sequencing of regions of 22 genes specific to these two types of cancers, the Cancer Hotspot Panel v2 offers more comprehensive functionality, supporting screening for mutations in 50 genes that typically mutate in a range of cancers, including melanoma, leukemia and breast cancer.

news sandra

Dr. Sandra Turcotte receives funding of close to a half-million dollars from the Canadian Institutes of Health Research for kidney cancer research


(Moncton, N.B.)—July 10, 2014— Dr. Sandra Turcotte, Canadian Cancer Society Research Chair, biochemistry professor at the Université de Moncton and research scientist at the Atlantic Cancer Research Institute (ACRI), has been awarded an operating grant by the Canadian Institutes of Health Research (CIHR). With this funding, valued at close to $500,000 over the next five years, she will be able to continue her research aimed at developing new strategies for the treatment of kidney cancer. In advanced stages, renal tumours are resistant to conventional chemotherapy treatments. Dr. Turcotte's approach involves the discovery of small molecules that target a common mutation specifically found within the cancerous kidney cells. Her team's work in this area is promising and their approach is innovative.

news dejeuner

Atlantic Cancer Research Institute and Prostate Cancer Canada announce Local Moncton Hero


Prostate Cancer Canada Atlantic Region and the Atlantic Cancer Research Institute announced that they are once again teaming up for Prostate Cancer Canada's annual Wake Up Call Breakfast. Chris Bacich, General Manager, BMW Moncton and Kevin Darling, VP Commercial Financial Services, Eastern NB & PEI, RBC are Co-Chairs of the 2014 Moncton Wake Up Call. Today they announced that His Worship, Mayor George LeBlanc will be the recipient of the 2014 Local Hero Award at the breakfast event on September 9th at Delta Beausejour.

img news campain

Over its first fifteen years the Atlantic Cancer Research Institute has had some significant accomplishments and now with the launch of a $10 million fundraising campaign the Institute is looking toward an even brighter future.

The focus of the campaign entitled "Cancer Research Saves Lives" is to increase awareness and attract support for cancer research in Atlantic Canada which is important for several reasons. "Atlantic Canada has the highest cancer rates in the country," according to ACRI President Dr. Rodney Ouellette. "In fact one in three Atlantic Canadians will be touched by cancer, something that is very concerning to us as a cancer research institute based in our region. Who better to focus on this issue than Atlantic Canadians?"

"In addition to the alarming cancer statistics in the region, we are the most underfunded area of the country when it comes to research dollars," Dr. Ouellette continued. "This campaign is about finding a cure and improving patient outcomes through research. We are conducting cutting edge research that will contribute to the global efforts on this disease and it is important for Atlantic Canadians to be part of the solutions in the field of cancer. It also allows us to keep our brightest minds in the region."

photo rodney ouellette
Chaque mois, la Fondation de la recherche en santé du Nouveau-Brunswick célèbre un(e) chercheur(e) en santé pour ses accomplissement en recherche en santé axée sur le patient, la médecine appliquée et l'innovation, en présentant leur recherche dans l'Acadie Nouvelle ainsi que dans le Telegraph Journal.

1
Dr. Louis-Marie Simard, Medical Director of the Dr. Georges-L.-Dumont University Hospital Centre
The Honorable Marie-Claude Blais, Minister of Education and Early Childhood Development, Minister responsible for Women's Equality
Mrs. Sandra Brady, patient
Dr. Rodney Ouellette, President and Scientific Director at the Atlantic Cancer Research Institute (ACRI)
Dr. Nicolas Crapoulet, research scientist at the ACRI
Dr. Dhany Charest, Chief of Medical Staff, Area 1H-Moncton of the Horizon Health Network
Monsieur Richard Losier, Chief Operating Officer –Zone 1 Beauséjour of the Vitalité Health Network

(Moncton, N.B.) – March 24, 2014 – Vitalité Health Network, in conjunction with the Atlantic Cancer Research Institute (ACRI), is pleased to announce that it is now offering  next-generation DNA sequencing technology for diagnostic purposes. After becoming one of the first research centres in Canada to acquire the Ion Proton Sequencer manufactured by Life Technologies, in 2012, ACRI is now making this device available for use by the molecular genetics laboratory at Dr. Georges-L.-Dumont University Hospital Centre.

logo institut3

The Atlantic Cancer Research Institute (ACRI), in partnership with TD Bank, is pleased to announce a call for applications for the TD Bank Cancer Research Training Awards at ACRI.

photo rodney ouellette 2

Media Coverage:

Acadie Nouvelle

CBC

blossom

Moncton Blossoms and Atlantic Cancer Research Institute Present “Blossom of Hope” for World Cancer Day

photo rodney ouellette

Feature article, Cole Hobson from the Times & Transcript interviews Dr. Rodney Ouellette for ACRI's Cancer Research updates

8

Atlantic Cancer Research Institute Acadia Life Holiday Challenge Campaign a Success!

(Moncton, NB) – January 10, 2014 – Throughout the month of December the Atlantic Cancer Research Institute (ACRI) and Acadia Life invited the public to make a donation through the Acadia Life Holiday Challenge. During this matching gift campaign, every donation made until January 5, 2014 was matched dollar for dollar by Acadia Life. We are pleased to announce that the campaign raised $47,750.00 for cancer research in Atlantic Canada.

Twitter

Archived Articles

btn campain EN
Atlantic Cancer Research Institute 
Pavillon Hôtel-Dieu
35, Providence Street
Moncton, NB E1C 8X3 Canada

info@canceratl.ca
Tel.: 506-862-7512
Fax.: 506-862-7571

Annual Report 2017 Cover
Our annual report
Download PDF bullet blanc

The Atlantic Cancer Research Institute

 (ACRI) is a non-profit organization founded in late 1998 and housed at the Dr. Georges-L.-Dumont University Hospital Centre in Moncton. Thanks to its unique expertise, ACRI has become a true centre of excellence in cancer research.

Our Partners

logo excipio logo chudumont logo soricimedlogo neplogo ccslogo umonctonlogo unblogo vitalitelogo conceptiaCRS logoNBHRF logoMerck Logo.svg